华安国证生物医药ETF发起式联接A(012598)资产负债表
| |
2024-06-30 |
2023-12-31 |
2023-06-30 |
2022-12-31 |
| 资产 |
| 银行存款 |
- |
- |
8,114,151.12 |
4,842,038.72 |
| 结算备付金 |
43,433.28 |
20,442.06 |
129,236.74 |
16,091.62 |
| 存出保证金 |
41,590.44 |
33,008.42 |
20,283.66 |
7,187.61 |
| 交易性金融资产 |
91,361,842.10 |
154,089,987.30 |
85,937,256.87 |
62,048,055.09 |
| 其中：股票投资 |
- |
- |
85,937,256.87 |
62,048,055.09 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
1,896,722.07 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
366,744.33 |
1,731,259.36 |
1,334,798.17 |
394,040.67 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
98,205,973.26 |
166,969,154.23 |
95,535,726.56 |
69,204,135.78 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
808,832.34 |
942,310.22 |
- |
| 应付赎回款 |
1,022,347.39 |
2,661,696.16 |
2,472,589.75 |
2,320,820.49 |
| 应付管理人报酬 |
2,656.60 |
3,791.42 |
36,327.87 |
22,515.60 |
| 应付托管费 |
531.32 |
758.27 |
7,265.59 |
4,503.13 |
| 应付销售服务费 |
13,606.78 |
20,812.63 |
13,735.54 |
8,099.92 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
1,765.57 |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
87,125.77 |
232,456.67 |
136,992.39 |
97,041.67 |
| 负债合计 |
1,126,267.86 |
3,730,113.06 |
3,609,221.36 |
2,452,980.81 |
| 所有者权益 |
| 实收基金 |
245,147,718.10 |
297,687,604.56 |
169,283,153.66 |
98,068,794.52 |
| 未分配利润 |
-148,068,012.70 |
-134,448,563.39 |
-77,356,648.46 |
-31,317,639.55 |
| 所有者权益合计 |
97,079,705.40 |
163,239,041.17 |
91,926,505.20 |
66,751,154.97 |
| 负债及所有者权益总计 |
98,205,973.26 |
166,969,154.23 |
95,535,726.56 |
69,204,135.78 |
微信公众号
证券之星APP
基本资料
